A Certificate of Analysis should answer a straightforward question: does this specific peptide batch match the material described by the supplier? This peptide CoA example explained is designed for buyers who want to assess that evidence properly, rather than treating a polished PDF as proof on its own.
For research compounds, the details matter. A CoA should connect to a defined batch, identify the tested material, state the analytical method and report results that can be interpreted in context. It is a quality-control record, not a marketing badge and not evidence that a material is approved for human use.
What a peptide CoA should show
A useful CoA begins with clear product and batch identification. Look for the peptide name, batch or lot number, batch size where available, manufacturing or testing date, and a unique document reference. The batch number on the certificate should match the batch information supplied with the product. If it does not, the document cannot verify the material in front of you.
A typical peptide CoA may include fields such as product name, molecular formula, molecular weight, appearance, identity result, purity result, water content, residual solvents and storage guidance. Not every test is relevant to every peptide or supplier format, but the core information should be specific enough to trace and assess.
For example, a certificate for a lyophilised research peptide may state:
Product: BPC-157
Batch number: BPC157-2406-01
Appearance: White to off-white lyophilised powder
Identity: Conforms by LC-MS
Purity: 99.2% by HPLC
Molecular weight: Observed mass consistent with theoretical mass
Test date: 14 June 2024
Result: Complies with specification
This is only an illustrative format. A real certificate should provide the supplier or laboratory identity, enough method detail to understand the result, and traceable batch information. A result without a batch number has limited value, regardless of how high the stated purity appears.
Peptide CoA example explained: the key fields
Identity confirms what was tested
Identity testing addresses whether the sample is consistent with the intended peptide. Liquid chromatography-mass spectrometry, usually written as LC-MS, is a common method. The chromatographic component separates compounds in a sample, while mass spectrometry measures ions associated with molecular mass.
A strong identity section does not need to provide raw instrument files on every document, but it should state the technique used and report a finding linked to the expected molecular weight. A simple statement such as “identity conforms” is more credible when paired with LC-MS or another named method than when no method is given at all.
Identity and purity are related but different. A sample can contain the intended peptide while also containing impurities, truncated sequences or process-related residues. That is why both results should be reviewed together.
Purity needs a method and a basis
For peptide buyers, purity is often the first figure noticed. HPLC purity of 99%+ is a useful quality marker, provided the certificate makes clear how that figure was obtained. High-performance liquid chromatography, or HPLC, separates components of a sample and estimates their relative proportion through peak area.
A report of “99.0% purity by HPLC” generally means the main chromatographic peak accounts for approximately 99.0% of the measured area under the stated conditions. It does not automatically mean 99.0% peptide content by weight, nor does it identify every remaining component. The distinction matters when comparing documents from different suppliers.
Where a CoA gives a purity figure, check for the method name, result, specification and, ideally, a chromatogram or a reference to one. A specification such as “not less than 99.0%” sets the acceptance threshold. A measured result of 99.3% shows the tested sample met that particular threshold.
Do not assume that the highest headline number is always the only deciding factor. A slightly lower result with clear batch traceability, named methods and recent testing can provide better purchasing confidence than an unsupported claim of exceptional purity.
Molecular weight supports the identity result
Peptides are defined by sequence, and sequence determines expected molecular weight. The CoA may list both a theoretical mass and an observed mass. These should be reasonably consistent, allowing for the measurement approach, salt form and ionisation state reported by the laboratory.
A major mismatch deserves an explanation. However, buyers should avoid over-interpreting a small numerical difference without knowing whether the document reports average molecular weight, monoisotopic mass, or a charged mass-to-charge ratio. The relevant point is that the laboratory has compared the analytical result against the expected material.
Dates show whether the document is current and relevant
A CoA should be dated. The test date identifies when the sample was analysed, while issue date may show when the certificate was released. These are not necessarily the same. For stable, properly stored lyophilised peptides, a test date is still more informative when considered alongside storage conditions, packaging and batch controls.
A document with no dates or no batch reference cannot establish current batch-level assurance. Equally, a recent document is not useful if it belongs to a different lot. Traceability takes priority over appearance.
What a CoA cannot tell you on its own
A certificate is one part of a quality assessment, not the entire assessment. It does not replace appropriate storage, controlled handling or a clear research-use framework. It also does not establish suitability for a particular experiment, biological activity in a specific model, sterility, endotoxin status or clinical safety unless those properties have been separately tested and explicitly reported.
This is particularly relevant when comparing vials with pre-filled formats. A CoA for the active compound may not describe the full finished presentation, diluent, fill accuracy or device performance. The documentation required depends on the exact product and the intended research context.
Similarly, HPLC purity does not confirm that a sample is sterile. Sterility is a separate test with its own method and specification. Buyers should only rely on claims that are directly stated and supported by the appropriate documentation.
Signs that warrant closer scrutiny
Some documents provide limited assurance even when they look professional. Be cautious where the product name is generic, the batch number is absent, the same certificate appears across unrelated batches, or the results are presented without methods or laboratory details.
Formatting alone proves very little. Logos, signatures and stamp graphics can be copied. More useful indicators are internal consistency and traceability: does the product name match, does the batch reference align, are the units sensible, is the method appropriate, and do the dates follow a coherent sequence?
Ask whether the certificate describes the exact material being supplied. A supplier should be able to explain its batch-control process clearly. For specialist research sourcing, this is more valuable than vague reassurance or broad claims with no supporting data.
How to use a CoA when comparing suppliers
Start with the batch number. Confirm that it is visible on the certificate and linked to the product you intend to purchase. Then review identity, purity and the methods used. Finally, consider the supplier’s wider controls: sourcing standards, packaging, storage practices and fulfilment reliability all affect the confidence you can place in the material reaching you as intended.
For UK buyers, prompt tracked delivery can reduce unnecessary time in transit, but it is not a substitute for analysis. The strongest purchasing decision combines practical fulfilment standards with clear, batch-level evidence. Biochemi applies this quality-led approach by prioritising documented analysis and 99%+ purity standards across its research peptide range.
A good CoA should make you more informed, not merely more reassured. When the batch, methods and results can be read together without gaps, you have a sounder basis for selecting research material with care.